International Multiple Sclerosis Genetics Consortium. The multiple sclerosis genomic map: Role of peripheral immune cells and resident microglia in susceptibility. BioRxiv2017. Available at: http://www.biorxiv.org/content/early/2017/07/13/143933
2.
IsobeNMadireddyLKhankhanianPet al. An ImmunoChip study of multiple sclerosis risk in African Americans. Brain2015; 138(Pt 6): 1518–1130.
3.
RheadBBäärnhielmMGianfrancescoMet al. Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk. Neurol Genet2016; 2(5): e97.
4.
XiaZSteeleSUBakshiAet al. Assessment of early evidence of multiple sclerosis in a prospective study of asymptomatic high-risk family members. JAMA Neurol2017; 74(3): 293–300.
5.
SondergaardHBPetersenERMagyariMet al. Genetic burden of MS risk variants distinguish patients from healthy individuals but are not associated with disease activity. Mult Scler Relat Disord2017; 13: 25–27.
6.
GeorgeMFBriggsFBShaoXet al. Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies. Neurol Genet2016; 2(4): e87.
7.
IsobeNKeshavanAGourraudPAet al. Association of HLA genetic risk burden with disease phenotypes in multiple sclerosis. JAMA Neurol2016; 73(7): 795–802.
8.
EspositoFSorosinaMOttoboniLet al. A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity. Ann Neurol2015; 78(1): 115–127.
9.
RajTRothamelKMostafaviSet al. Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes. Science2014; 344(6183): 519–123.
XiaZWhiteCCOwenEKet al. Genes and environment in multiple sclerosis project: A platform to investigate multiple sclerosis risk. Ann Neurol2016; 79(2): 178–189.
